Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972225priorityCriticalpatent/ECSP972225A/en
Publication of ECSP972225ApublicationCriticalpatent/ECSP972225A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Se obtiene alivio de los sintomas de rinitis mediante tratamiento con (a) una cantidad antihistamínica eficaz de un antagonista receptor de histamina H1, conjuntamente con (b) una cantidad suficiente de un antagonista receptor de histamina H3 para proveer un efecto descongestivo nasal. Los componentes pueden administrarse en una forma de dosificación conjunta única, o por separado en formas de dosificación iguales o diferentes para mantener los niveles sistámicos terapéuticos de ambos componentes.Relief of the symptoms of rhinitis is obtained by treatment with (a) an effective antihistamine amount of a histamine H1 receptor antagonist, together with (b) a sufficient amount of a histamine H3 receptor antagonist to provide a nasal decongestant effect. The components can be administered in a single co-dosage form, or separately in the same or different dosage forms to maintain therapeutic systemic levels of both components.
ECSP9722251997-08-131997-08-13
TREATMENT OF ALLERGIC RESPONSES OF THE SUPERIOR RESPIRATORY TRACT (CASE AL0642K)
ECSP972225A
(en)
USE OF AN EFFECTIVE AMOUNT OF A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT, WELL IN COMBINED FORM ONLY OR SEPARATELY, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD TO PREPARE THEM, AND USE OF A COMPOSITION THAT INCLUDES AN EFFECTIVE AMOUNT OF A PDD AN EFFECTIVE AMOUNT
A COMPOSITION FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS AND THE USE OF A GLUTAMATE ANTAGONIST FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS